UGS-18055-10395
2 vaccinations
6 coded responses
19 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 232 / VA
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- DLW-53466-14354
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-28
Dose 1 — Pfizer-BioNTech
-
2022-06-29
Registered in v-safe
-
2022-06-29
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-07-01
- 2022-07-02
- 2022-07-04
- 2022-07-05
- 2022-07-12
-
2022-07-19
Dose 2 — Pfizer-BioNTech
- 2022-07-19
-
2022-07-20
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-07-21
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Nasal congestion — Feeling: Fair · Site: Pain · FeverFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-23
-
2022-07-25
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-07-26
Survey response — day 7, dose 2, dependentMedDRA: Nasal congestion, Rhinorrhoea — Feeling: GoodFree text: Runny stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Survey response — day 14, dose 2, dependentMedDRA: Fatigue, Nasal congestion, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Low grade fever, runny stuffy nose, and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-08-09
- 2022-08-18
- 2022-08-23
-
2022-10-18
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Lower respiratory tract infection, Nasal congestion, Nasopharyngitis, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Head and chest cold. Runny stuffy nose, coughing, and fever 99.7 to 100.7MedDRA releases: 2024-11 · check-in free text available
- 2023-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-28 | Pfizer-BioNTech | No |
| 2 | 2022-07-19 | Pfizer-BioNTech | No |
Free text
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Sore throat
Systemic reaction (other): Stuffy nose
Systemic reaction (other): Sore throat
Release 12 — day 7, dose 2, dependent
Systemic reaction (other): Runny stuffy nose
Release 12 — day 14, dose 2, dependent
Symptoms: Low grade fever, runny stuffy nose, and fatigue
Release 12 — 3 months, dose 2, dependent
Symptoms: Head and chest cold. Runny stuffy nose, coughing, and fever 99.7 to 100.7
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lower respiratory tract infection | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release